1 Department of Radiotherapy, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, and Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; German Cancer Consortium, partner site Dresden: University Hospital C.G. Carus Dresden and German Cancer Research Center Heidelberg, Germany.
2 Department of Radiotherapy, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, and Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; German Cancer Consortium, partner site Dresden: University Hospital C.G. Carus Dresden and German Cancer Research Center Heidelberg, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Germany. Electronic address: Mechthild.Krause@uniklinikum-dresden.de.
3 Department of Radiotherapy, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, and Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; German Cancer Consortium, partner site Dresden: University Hospital C.G. Carus Dresden and German Cancer Research Center Heidelberg, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Germany; German Cancer Research Center Heidelberg, Germany.